Physician profile
Michael Anthony Dirico
NPI 1518454685
$2,389.12
in general payments reported to CMS, 2019-2025
10 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $99.40 · 2023: $128 · 2024: $1,693 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,056 · Food and Beverage: $922 · Education: $79.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,056.14 |
| Food and Beverage | $922.00 |
| Education | $79.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,335.82 | 2024 | Illumisite |
| Pulmonx Corporation | $217.53 | 2024-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Glaxosmithkline, LLC. | $158.79 | 2019-2025 | Nucala, Trelegy Ellipta |
| Galvanize Therapeutics, INC | $137.15 | 2024 | Aliya System |
| Astrazeneca Pharmaceuticals LP | $127.50 | 2023 | Imfinzi |
| Genentech USA, INC. | $125.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $114.87 | 2025 | Dupixent |
| Celgene Corporation | $99.40 | 2020 | |
| Olympus America INC. | $59.04 | 2024 | Single-Use Flexible Video Bronchoscope |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.02 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dirico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.